
### [NCIT:C26903](http://purl.obolibrary.org/obo/NCIT_C26903)
**Label:** Urethra Disorder

**Subclasses:** [NCIT:C7508](http://purl.obolibrary.org/obo/NCIT_C7508) (Recurrent Urethra Carcinoma), [NCIT:C7507](http://purl.obolibrary.org/obo/NCIT_C7507) (Malignant Urethral Neoplasm), [NCIT:C4531](http://purl.obolibrary.org/obo/NCIT_C4531) (Stage 0is Urethral Cancer), [NCIT:C4378](http://purl.obolibrary.org/obo/NCIT_C4378) (Accessory Urethral Gland Neoplasm), [NCIT:C4532](http://purl.obolibrary.org/obo/NCIT_C4532) (Benign Accessory Urethral Gland Neoplasm), [NCIT:C115334](http://purl.obolibrary.org/obo/NCIT_C115334) (Proximal Urethral Carcinoma), [NCIT:C9106](http://purl.obolibrary.org/obo/NCIT_C9106) (Urethral Carcinoma), [NCIT:C6199](http://purl.obolibrary.org/obo/NCIT_C6199) (Stage III Urethral Cancer), [NCIT:C26903](http://purl.obolibrary.org/obo/NCIT_C26903) (Urethra Disorder), [NCIT:C115210](http://purl.obolibrary.org/obo/NCIT_C115210) (Distal Urethral Carcinoma), [NCIT:C6196](http://purl.obolibrary.org/obo/NCIT_C6196) (Stage 0a Urethral Cancer), [NCIT:C6195](http://purl.obolibrary.org/obo/NCIT_C6195) (Stage 0 Urethral Cancer), [NCIT:C6173](http://purl.obolibrary.org/obo/NCIT_C6173) (Urethral Inverted Papilloma), [NCIT:C3561](http://purl.obolibrary.org/obo/NCIT_C3561) (Malignant Accessory Urethral Gland Neoplasm), [NCIT:C6198](http://purl.obolibrary.org/obo/NCIT_C6198) (Stage II Urethral Cancer), [NCIT:C6197](http://purl.obolibrary.org/obo/NCIT_C6197) (Stage I Urethral Cancer), [NCIT:C39872](http://purl.obolibrary.org/obo/NCIT_C39872) (Urethral Villous Adenoma), [NCIT:C7371](http://purl.obolibrary.org/obo/NCIT_C7371) (Accessory Urethral Gland Carcinoma), [NCIT:C39874](http://purl.obolibrary.org/obo/NCIT_C39874) (Urethral Verrucous Carcinoma), [NCIT:C27819](http://purl.obolibrary.org/obo/NCIT_C27819) (Metastatic Urethral Neoplasm), [NCIT:C3428](http://purl.obolibrary.org/obo/NCIT_C3428) (Urethra Neoplasm), [NCIT:C7639](http://purl.obolibrary.org/obo/NCIT_C7639) (Regional Malignant Urethral Neoplasm), [NCIT:C6167](http://purl.obolibrary.org/obo/NCIT_C6167) (Urethral Adenocarcinoma), [NCIT:C6200](http://purl.obolibrary.org/obo/NCIT_C6200) (Stage IV Urethral Cancer), [NCIT:C6166](http://purl.obolibrary.org/obo/NCIT_C6166) (Urethral Urothelial Carcinoma), [NCIT:C6169](http://purl.obolibrary.org/obo/NCIT_C6169) (Urethral Condyloma Acuminatum), [NCIT:C6168](http://purl.obolibrary.org/obo/NCIT_C6168) (Undifferentiated Urethral Carcinoma), [NCIT:C7573](http://purl.obolibrary.org/obo/NCIT_C7573) (Metastatic Malignant Neoplasm in the Urethra), [NCIT:C6165](http://purl.obolibrary.org/obo/NCIT_C6165) (Urethral Squamous Cell Carcinoma), [NCIT:C39862](http://purl.obolibrary.org/obo/NCIT_C39862) (Human Papillomavirus-Related Urethral Squamous Cell Carcinoma), [NCIT:C6172](http://purl.obolibrary.org/obo/NCIT_C6172) (Urethral Clear Cell Adenocarcinoma), [NCIT:C39864](http://purl.obolibrary.org/obo/NCIT_C39864) (Carcinoma of Cowper Glands), [NCIT:C6171](http://purl.obolibrary.org/obo/NCIT_C6171) (Urethral Leiomyoma), [NCIT:C5061](http://purl.obolibrary.org/obo/NCIT_C5061) (Urethral Urothelial Papilloma), [NCIT:C131218](http://purl.obolibrary.org/obo/NCIT_C131218) (Recurrent Urethral Urothelial Carcinoma), [NCIT:C39866](http://purl.obolibrary.org/obo/NCIT_C39866) (Female Urethral Malignant Neoplasm), [NCIT:C39865](http://purl.obolibrary.org/obo/NCIT_C39865) (Carcinoma of Littre Glands), [NCIT:C3619](http://purl.obolibrary.org/obo/NCIT_C3619) (Benign Urethral Neoplasm), [NCIT:C39867](http://purl.obolibrary.org/obo/NCIT_C39867) (Male Urethral Malignant Neoplasm), 

**Class expressions from DL-Learner:**

- [NCIT:C26903](http://purl.obolibrary.org/obo/NCIT_C26903) (Urethra Disorder) 98.75%
- [NCIT:C3428](http://purl.obolibrary.org/obo/NCIT_C3428) (Urethra Neoplasm) 97.50%
- [NCIT:C7507](http://purl.obolibrary.org/obo/NCIT_C7507) (Malignant Urethral Neoplasm) 86.25%
- [NCIT:C9106](http://purl.obolibrary.org/obo/NCIT_C9106) (Urethral Carcinoma) 77.50%
- [NCIT:C3430](http://purl.obolibrary.org/obo/NCIT_C3430) (Urinary System Disorder) 67.02%
- [NCIT:C3431](http://purl.obolibrary.org/obo/NCIT_C3431) (Urinary System Neoplasm) 65.82%
- [NCIT:C9297](http://purl.obolibrary.org/obo/NCIT_C9297) (Malignant Urinary System Neoplasm) 54.36%
- Thing 52.76%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 52.71%
- [NCIT:C2991](http://purl.obolibrary.org/obo/NCIT_C2991) (Disease or Disorder) 52.59%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 52.58%
- [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) 51.52%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 51.39%
- [NCIT:C7062](http://purl.obolibrary.org/obo/NCIT_C7062) (Neoplasm by Special Category) 38.75%
- [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) 37.39%


